Skip to main content

Vor Bio to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:

Stifel 2023 Healthcare Conference
Fireside Chat: Tuesday, November 14, 2023 at 3:35 pm ET
Location: Lotte New York Palace Hotel, New York, NY

A live webcast and archived replay of the fireside chat will be available on the investors section of www.vorbio.com.

6th Annual Evercore ISI HealthCONx Conference
Fireside Chat: Wednesday, November 29, 2023 at 3:00 pm ET
Location: Kimpton EPIC Hotel, Miami, FL

Piper Sandler 35th Annual Healthcare Conference
Fireside Chat: Thursday, November 30, 2023 at 2:00 pm ET
Location: Lotte New York Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com

 


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.98
-1.04 (-0.42%)
AAPL  264.68
+5.85 (2.26%)
AMD  256.07
+1.00 (0.39%)
BAC  54.28
+0.93 (1.75%)
GOOG  330.64
+0.06 (0.02%)
META  674.88
+12.38 (1.87%)
MSFT  407.25
+14.13 (3.60%)
NVDA  199.38
+2.87 (1.46%)
ORCL  170.95
+7.95 (4.88%)
TSLA  391.26
+27.06 (7.43%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.